FDA, Merck, and Vioxx : Putting Patient Safety First?: Congressional Hearing

Witnesses: David J. Graham, Assoc. Dir. for Science, Office of Drug Safety, Center for Drug Evaluation & Research, Food & Drug Admin. (FDA); Sandra L. Kweder, Acting Dir., Office of New Drugs, Center for Drug Evaluation & Research, FDA; Bruce M. Psaty, Prof., Medicine & Epidemiology, Univ. of Wash., Cardiovascular Health Research Unit, Seattle, WA; Gurkipal Singh, Adjunct Clinical Prof. of Medicine, Div. of Gastroenterology & Hematology, Dept. of Medicine, Stanford Univ. School of Medicine; & Raymond V. Gilmartin, chmn., Pres. & CEO, Merck & Co., Whitehouse Station, NJ. Also includes: opening statements by members of the Comm. on Finance, U.S. Senate; & a communication from Eric J. Topol. Illustrations.Grassley, Charles E. is the author of 'FDA, Merck, and Vioxx : Putting Patient Safety First?: Congressional Hearing', published 2006 under ISBN 9781422304877 and ISBN 1422304876.